David Shaw

Company: Genentech

Job title: Senior Director & Head of Cell Therapy Engineering & Process Development

Seminars:

Roundtable Discussion: Precision Manufacturing in Allogeneic Cell Therapy by Overcoming Donor Variability, Gene Editing & Scale-Up Challenges 12:15 pm

Standardizing Donor Material: Tackling donor-to-donor variability and setting clear criteria for starting material quality Optimizing Gene Editing Strategies: Managing complex edits for immune evasion, persistence, and maintaining product consistency across multiple modifications Scaling Up Production and Fill-Finish: Addressing challenges in bioreactor selection, large-scale expansion, and efficient fill-finish solutions for high-volume therapiesRead more

day: Roundtable Discussion Track B

Panel Discussion: The Process Development Playbook — Insights from Industry Veterans & Commercialized Products 8:30 am

Behind the Scenes of Successful Process Scaling: Key strategies and lessons learned from scaling processes while maintaining quality and efficiency Navigating Common Roadblocks in Process Development: Practical tips for overcoming bottlenecks, variability, and resource challenges The Future of Cell Therapy Development — What’s Next and How to Stay Ahead: Emerging technologies and trends shaping the…Read more

day: Conference Day One